The largest database of trusted experimental protocols

Mitomycin c mmc

Manufactured by Merck Group
Sourced in United States, Germany

Mitomycin C (MMC) is a laboratory-grade reagent manufactured by Merck Group. It is a DNA-alkylating agent used in various research applications, including the study of cellular processes, DNA damage response, and cancer biology. MMC functions by forming covalent crosslinks between DNA strands, which can lead to cell cycle arrest and cell death. This product is intended for research purposes only and should be handled with appropriate safety precautions.

Automatically generated - may contain errors

72 protocols using mitomycin c mmc

1

Ovarian Cancer Cell Line Maintenance and Characterization

Check if the same lab product or an alternative is used in the 5 most similar protocols
Epithelial OC cell lines (A2780, A2780_CR5, SKOV3, HEYC2, OV90, IOSE, IGROV, OVMUNA, OV90) were maintained in RPMI 1640 medium (Invitrogen, Carlsbad, CA) as described previously [50 (link)]. Cisplatin-resistant A2780_CR5 was established by continuous exposure to increasing concentrations of cisplatin [50 (link)]. Cell lines were authenticated in 2012 by ATCC and tested for mycoplasma contamination (Manassas, VA). High-grade serous ovarian tumors (unpaired samples; chemo-naïve, stage 3–4 or recurrent, platinum resistant), and ovarian surface epithelium (OSE) were surgically collected with informed consent from all subjects (IRB approved protocol IUCRO-0280), snap-frozen, and stored in liquid nitrogen [51 (link)]. Cisplatin (CDDP) was purchased from Calbiochem (Billerica, MA), mitomycin C (MMC) was purchased from Sigma Chemical Co. (St. Louis MO), and H2O2 was purchased from EMD Millipore (Billerica, MA). NF-κB inhibitor Bay-11–7082 was purchased from Santa Cruz Biotech (Santa Cruz, CA). LZRS-HOTAIR was a gift from Dr. Howard Chang (Stanford University; Addgene plasmid # 26110). Full-length HOTAIR was cloned into pAV5S vector containing a 98-mer aptamer sequence and as a vector control, aptamer cloned into pAV5S was used to account for any possible RNA-dependent signaling effects [52 (link)].
+ Open protocol
+ Expand
2

Evaluating FANCA Plasmid Transfection

Check if the same lab product or an alternative is used in the 5 most similar protocols
U2OS cells were purchased from the Cell Bank of the Chinese Academy of Sciences (Shanghai, China). U2OS cells were cultured in DMEM (Gibco) supplemented with 10% FBS (Gibco) and 1% penicillin–streptomycin–neomycin (PSN) antibiotic mixture (Gibco) at 37 °C with 5% CO2. To evaluate the transfection efficiency, FANCA plasmids were co-transfected with pEGFP-N2 vector (Clontech) into U2OS cells using Lipofectamine 3000 (Invitrogen) according to the manufacturer’s instructions. In experiments evaluating cell sensitivity to ICL damage, 2 μM mitomycin C (MMC; Sigma) was added into the culture medium 24 h after transfection.
+ Open protocol
+ Expand
3

Cytogenetic Assay Reagents and Protocols

Check if the same lab product or an alternative is used in the 5 most similar protocols
Fetal bovine serum (FBS), Ham’s F-10 medium, and Phytohaemaglutinin (PHA) were commercially procured by Gibco (Fisher Scientific, Loughborough, Leicestershire, UK Ltd). Mitomycin C (MMC) and Cytochalasin-B (Cyt-B) were purchased from Sigma-Aldrich Chemical Co. (St. Louis, MO, USA). All other chemicals and solvents were of the highest grade commercially available. Stocks of the compounds and solutions were stored at 4 °C until use. Treatments were performed and based on the initial stocks of the tested compounds.
+ Open protocol
+ Expand
4

Mitomycin C-treated MSCs for T-cell co-culture

Check if the same lab product or an alternative is used in the 5 most similar protocols
BM-MSCs and normal fibroblast cells (WI38) were purchased from Cambrex Bioscience Walkersville (East Rutherford, NJ, USA) and ATCC (Manassas, VA, USA), respectively. Cells were cultured in alpha-MEM (Invitrogen, Carlsbad, CA, USA) containing 10% fetal bovine serum (FBS), 1% penicillin/streptomycin (P/S, 100 mg/mL; Gibco-BRL, NY, USA), and 2 mM l-glutamine (Gibco-BRL). PD-MSCs were harvested from the inner side of the chorioamniotic membrane of the placenta as described previously (16 (link)). PD-MSCs and BM-MSCs at passages 6 to 8 were used for assays. The cells were treated with 50 μg/mL of mitomycin C (MMC; Sigma-Aldrich) for 50 min to stop cell division and then used as feeder cells for co-culture with naïve or stimulated T cells isolated from peripheral blood (PB).
+ Open protocol
+ Expand
5

Cell Viability Assay for Genotoxic Agents

Check if the same lab product or an alternative is used in the 5 most similar protocols
Cells were seeded into 96 well plates (4000 cells/well) and incubated for 4 hours before treatment with methyl methanesulfonate (MMS) (Sigma-Aldrich, Saint Louis, MO, USA), mitomycin-C (MMC) (Sigma-Aldrich), cisplatin (Hospira) or UVB (Vilber Lourmat, Bio Spectra V5, 312 nm, cells exposed in 100 μL medium, additional 100 μL added after UVB exposure). The drugs were added on day 0, and cells were analyzed 24, 48 and 72 h after UVB treatment and 24, 72 and 96 h after MMC, MMS and cisplatin treatment. MTT (3-(4.5-Dimethylthiazol-2-yl)-2.5 diphenyl-tetrazolium bromide) was added to the cells and OD was measured at 565 nm, and the average from at least 6 wells was used to calculate cell survival.
+ Open protocol
+ Expand
6

Cell Fractionation and Mitomycin C Exposure

Check if the same lab product or an alternative is used in the 5 most similar protocols
U2OS and HT1080 cells were obtained from ATCC and maintained as recommended. Cell fractionation was carried out using the Subcellular Protein Fractionation Kit (ThermoFisher Scientific) and as described by the manufacturer. Exposure of cells to 1 μM mitomycin C (MMC; Sigma) occurred in regular growth medium at 37 °C for 24 h.
+ Open protocol
+ Expand
7

Evaluating DNA Repair Efficiency Using Chromosome Breakage Assay

Check if the same lab product or an alternative is used in the 5 most similar protocols
Hypersensitivity to the chromosome-breaking effect of crosslinking agents is a reliable marker of homologous recombination (HR) efficiency.11 (link) For POI genes involved in DNA repair and not expressed exclusively in germ cells, chromosomal breakage studies were performed in cultures of peripheral lymphocytes obtained from the patient, the mother when available, and a healthy woman as a control. The experiments were performed at the Gustave Roussy Institute (Villejuif, France), following a standard in-house protocol.7 (link), 8 (link), 9 (link),12 (link) Fresh peripheral blood lymphocytes were cultured under standard conditions for karyotyping. DNA damage was induced by treating the cells with mitomycin C (MMC; Sigma) for 48 h to examine cellular hypersensitivity to DNA crosslinking agents. Three treatment conditions were used: without MMC to analyze spontaneous DNA damage and with 150 or 300 nM MMC as recommended.11 (link) Chromosome breaks were scored by an experienced cytogeneticist using at least 20 metaphases.
+ Open protocol
+ Expand
8

Recombinant Protein Expression in E. coli and H. volcanii

Check if the same lab product or an alternative is used in the 5 most similar protocols
The oligonucleotides used in this study were purchased from Takara (Dalian, China). Escherichia coli strain DH5α was used for gene cloning, and the Rosetta2(DE3)pLysS strain was used for recombinant protein expression. The expression vectors pET28a and pDEST17 were used to express recombinant proteins. The H. volcanii strain and plasmids for gene knockout were provided by Dr Allers (University of Nottingham, UK). Pyrococcus furiosus genomic DNA was purchased from the American Type Culture Collection (ATCC). KOD-plus DNA polymerase was purchased from Toyobo. Nickel–nitrilotriacetic acid resin was purchased from Bio-Rad. The crosslinking reagent BS3 and the DNA damage reagents 4-nitroquinoline-1-oxide (4NQO), mitomycin C (MMC), and methyl methanesulfonate (MMS), methyl methanesulfonate (MMS), N3-methyladenine and adenine were purchased from Sigma–Aldrich (St Louis, MO). All other chemicals and reagents were of analytical grade.
+ Open protocol
+ Expand
9

Cytogenetic Evaluation of Potassium Tetraborate

Check if the same lab product or an alternative is used in the 5 most similar protocols
The heparinized blood samples were collected from four healthy males aged from 25 to 30 years old, respectively, non-smoking, non-alcoholic, not under drug therapy and with no recent history of exposure to mutagens. Human peripheral blood cultures were set up according to a slight modification of the protocol described by Evans and O’Riordan (1975[7 (link)]). The heparinized blood (0.5 ml) was cultured in 6 ml of culture medium (Chromosome Medium B, Biochrom, Berlin, Germany) with 5 mg/ml of phytohemagglutinin (Biochrom). Potassium tetraborate (K2B4O7, CAS Number 12045-78-2) was synthetized previously described by Marezio et al. (1963[15 ]) and dissolved in distilled water and it was added to the cultures just before incubation in concentrations of 1.25, 2.5, 5, 10, 20, 40, 80, 160, 320, 640 and 1280 µg/ml. Each individual blood culture without PTB was studied as a control group. The concentrations were selected according to the works of Turkez et al. (2007[25 ]). Mitomycin C (MMC; 10-7 M, Sigma-Aldrich®) was used as the positive control in CA and MN assays. Ascorbic acid (10 µM, Sigma-Aldrich®) and hydrogen peroxide (25 µM, Sigma-Aldrich®) were also used as the positive controls in TAC and TOS analysis, respectively.
+ Open protocol
+ Expand
10

Fanca and Fancc Knockout Mouse Model

Check if the same lab product or an alternative is used in the 5 most similar protocols
Fanca+/+, Fanca/ and Fancc+/+, and Fancc/ mice were generated by interbreeding the heterozygous Fanca+/ or Fancc+/ mice,26 (link),27 (link) respectively. Luc-Fanca+/+, Luc-Fanca/ and Luc-Fancc+/+ mice were generated by interbreeding the heterozygous Luc-Gadd45β mice28 (link) with Fanca+/ mice. All the animals including BoyJ mice were maintained in the animal barrier facility at Cincinnati Children’s Hospital Medical Center. For in vivo mitomycin C (MMC; Sigma-Aldrich, St Louis, MO, USA) treatment, 6–8-week-old mice or their male wild-type littermates were weekly intraperitoneal injected with 0.3 mg/kg of MMC.29 (link)
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!